Springer Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics

This comprehensive volume from Springer presents a decade of advances in hematologic cancer research, bringing together expert perspectives on disease pathobiology and modern treatment strategies. The book covers the explosive growth in molecular biology and pathology knowledge that has transformed understanding of malignant hematologic diseases, from cytogenetic foundations to clinical applications. Designed for medical professionals, researchers, and allied health practitioners, this volume synthesises current knowledge on disease molecular pathology and emerging therapeutic approaches, offering both foundational science and practical insights into the management of blood cancers. As part of the Cancer Growth and Progression series, it represents cutting-edge scholarship in haematology and oncology.